financetom
Business
financetom
/
Business
/
Update: Viasat Shares Surge After Fiscal Q1 Beat
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Viasat Shares Surge After Fiscal Q1 Beat
Aug 8, 2024 10:39 AM

01:27 PM EDT, 08/08/2024 (MT Newswires) -- (Updates with the stock price movement in the headline and the first paragraph.)

Viasat ( VSAT ) shares jumped nearly 40% in recent Thursday trading, a day after the company reported its fiscal Q1 results that surpassed market expectations.

The company reported fiscal Q1 adjusted earnings late Wednesday of $0.30 per diluted share, compared with breakeven earnings a year earlier.

Three analysts polled by Capital IQ expected earnings of $0.06 per share.

Revenue for the quarter ended June 30 was $1.13 billion, up from $779.8 million a year earlier.

Analysts polled by Capital IQ expected $1.07 billion.

The company said it expects revenue growth for fiscal 2025 to be up mid-single digits.

Price: 24.82, Change: +7.05, Percent Change: +39.67

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
FedEx shares slide as trade turbulence hits demand, profit forecast
FedEx shares slide as trade turbulence hits demand, profit forecast
Jun 25, 2025
(Reuters) -FedEx shares dropped nearly 6% in premarket trading on Wednesday after the logistics giant sounded caution for the full year ahead and forecast current-quarter earnings below market expectations, as it battles volatile global demand due to pressures from U.S. tariffs. The global demand environment remains volatile, said CEO Raj Subramaniam during an earnings webcast, as the company failed to...
Alvotech Says Proposed Xolair Biosimilar Study Meets Primary Endpoint
Alvotech Says Proposed Xolair Biosimilar Study Meets Primary Endpoint
Jun 25, 2025
05:07 AM EDT, 06/25/2025 (MT Newswires) -- Alvotech ( ALVO ) , Kashiv Biosciences, and Advanz Pharma said Wednesday that an efficacy study comparing AVT23, a proposed biosimilar to Xolair, in patients with chronic spontaneous urticarial met its primary endpoint. The study covered patients who remained symptomatic despite treatment with H1 antihistamines. The companies said the results showed equivalence of...
Bosch CEO warns Europe against regulating 'itself to death' on AI
Bosch CEO warns Europe against regulating 'itself to death' on AI
Jun 25, 2025
FRANKFURT, June 25 (Reuters) - Bosch CEO Stefan Hartung warned on Wednesday that Europe risks hindering its progress in artificial intelligence compared with other parts of the world through over-regulation. Europe is unnecessarily delaying its AI future with excessive regulation, said Hartung at a tech conference the German firm is hosting in the south-western city of Stuttgart. Bosch, which holds...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved